Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine versus fentanyl for prevention of rebound pain after open surgery under spinal anesthesia
PACTR202310515862483Phase 3Completed
- Sponsor
- Mansoura University Hospitals
- Start
- Jun 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing Spinal anesthesia with dexmedetomidine adjuvant with Spinal anesthesia with fentanyl adjuvant (2 arms). Primary endpoint: Incidence of rebound pain after wearing off of the spinal anesthesia. Started Jun 2022; status: completed.
02
Drugs
dexmedetomidinefentanyl
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202310515862483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202310515862483.